MetaVia is trading at $1.29, up +5.28% on October 20, 2026, with the specific catalyst unclear.
- No new company-specific announcement explaining the move was found.
- The latest company announcement located was the October 13 appointment of Sarah Browne as Chief Medical Officer; it does not establish the cause of the move.
- Supplied market context is mixed and does not clearly explain the gain.